Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 353 clinical trials
Featured trial
Tralokinumab monotherapy for moderate to severe atopic dermatitis

Clinical research study for the treatment of moderate to severe atopic dermatitis.

  • 1371 views
  • 07 Nov, 2020
  • 1 location
Featured trial
Allergic Contact Dermatitis study for 12-54 years of age

Have you been suffering with Allergic Contact Dermatitis (skin rash, hives, etc.) We have a new trial opening for children and adults who have been diagnosed with moderate to severe Allergic

allergic contact dermatitis
  • 368 views
  • 05 Jun, 2020
  • 1 location
Featured trial
Studies for the Treatment of Atopic Dermatitis (eczema)

Studies for the Treatment of Atopic Dermatitis (eczema)

  • 840 views
  • 08 Nov, 2020
  • 1 location
Featured trial
INCB 18424-304: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 2 (TRuE-AD2) for 304

A Phase 3, randomized (2:2:1), double-blind, 8-week vehicle control efficacy and safety study of ruxolitinib followed by a randomized, double-blind, 44-week long term safety (LTS) extension period.  In the LTS period,  participants initially randomized to vehicle will receive either ruxolitinib 0.75% or 1.5% cream.  All participants will have follow-up assessments …

eczema
atopic dermatitis
atopic dermatitis/eczema
dermatitis
  • 423 views
  • 03 May, 2022
  • 11 locations
Featured trial
INCB 18424-303: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE-AD1)

A Phase 3, randomized (2:2:1), double-blind, 8-week vehicle control efficacy and safety study of ruxolitinib followed by a randomized, double-blind, 44-week long term safety (LTS) extension period.  In the LTS period,  participants initially randomized to vehicle will receive either ruxolitinib 0.75% or 1.5% cream.  All participants will have follow-up assessments …

eczema
atopic dermatitis
atopic dermatitis/eczema
  • 582 views
  • 10 May, 2022
  • 19 locations
Featured trial
We are currently recruiting participants for the BLUEPRINT study. This study investigates the effectiveness, safety, and tolerability of the drug BLU-5937 for chronic itch in people with eczema.

The BLUEPRINT study consists of taking two tablets orally, twice a day, for a period of 4 weeks. This treatment is experimental. You will have 50% chance to receive BLU-5937 and 50% chance to receive the placebo. There will be a total of 5 visits at the clinic and 2 …

eczema
adult atopic dermatitis
dermatitis
atopic dermatitis
atopic dermatitis/eczema
  • 71 views
  • 10 Dec, 2020
  • 25 locations
Featured trial
Integument-2 study

We are currently recruiting pediatric and adult patients with mild to moderate atopic dermatitis (eczema) for a study that investigates the safety and efficacy of the ARQ-151 cream.

  • 0 views
  • 04 May, 2022
  • 55 locations
Featured trial
Integument-1 study

We are currently recruiting pediatric and adult patients with mild to moderate atopic dermatitis (eczema) for a study that investigates the safety and efficacy of the ARQ-151 cream. 

  • 0 views
  • 04 May, 2022
  • 54 locations
Featured trial
Integument-PED study

We are currently recruiting pediatric and adult patients with mild to moderate atopic dermatitis (eczema) for a study that investigates the safety and efficacy of the ARQ-151 cream. 

  • 44 views
  • 17 May, 2022
  • 76 locations
Featured trial
Eczema Research Study - Compensation up to $420

  If you have symptoms of eczema such as itchy red patches you may qualify for a Research Study. Qualified participants receive study-related exams, medication and care from a board-certified dermatologist at no cost.  

  • 223 views
  • 23 Nov, 2020
  • 1 location